UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 13, 2013
Streamline Health Solutions, Inc.
(Exact name of registrant as specified in its charter)
|
Delaware |
|
0-28132 |
|
31-1455414 |
|
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
1230 Peachtree Street, NE, Suite 1000,
Atlanta, GA 30309
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code (404) 446-0050
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 — Regulation FD Disclosure.
Streamline Health Solutions, Inc. (the “Company”) is furnishing presentation materials to be discussed at Avondale Partners’ Healthcare 1-1 Conference in Boston, Massachusetts on August 14, 2013, included as Exhibit 99.1 to this Current Report on Form 8-K. The Company undertakes no obligation to update these presentation materials in the future, except as may be required by law.
The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act.
Item 9.01 — Financial Statements and Exhibits.
(d) Exhibits
|
EXHIBIT |
|
DESCRIPTION |
|
|
|
|
|
99.1 |
|
Streamline Health Solutions, Inc. Presentation Materials presented on August 14, 2013. |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
Streamline Health Solutions, Inc. | |
|
|
| |
|
Date: August 13, 2013 |
By: |
/s/ Nicholas A. Meeks |
|
|
|
Nicholas A. Meeks |
|
|
|
Chief Financial Officer |
INDEX TO EXHIBITS
|
Exhibit No. |
|
Description of Exhibit |
|
|
|
|
|
99.1 |
|
Streamline Health Solutions, Inc. Presentation Materials presented on August 14, 2013. |
Exhibit 99.1
|
|
Investor Presentation August 2013 NASDAQ: STRM Knowledge Management Solutions for Healthcare Providers |
|
|
Disclosure Statements TRADEMARKS Product or company names referenced herein may be trademarks or registered trademarks of their respective owners. |
|
|
Our Knowledge Management solutions aggregate unstructured and fragmented data across the clinical and financial spectrum of an admission or a visit– providing clients with intelligently organized, easily accessible insights, enabling better decision-making and better financial results. Knowledge management solutions provider Streamline Health: A Clear Way Forward Integrate with leading EMR, financial and clinical systems High client retention with deeply embedded solutions Installed base of top tier clients presents sizable opportunity SaaS model enhances recurring revenue profile – TTM Q1 2013 vs. TTM Q1 2012 recurring revenue grew 45%. Highly scalable SaaS model Management team with extensive healthcare information technology experience in both public and private equity or venture backed entities. Proven management team The increasing complexity of provider reimbursement strategies coupled with the demands of EHR implementations and a shift in coding metrics are drivers for growth. Macro market conditions driving growth 95% client retention due to subject matter expertise coupled with innovative, deep and broad solutions that integrate with the existing business process of our clients while delivering meaningful ROI. |
|
|
Addressing Critical Healthcare Issues Electronic Medical Records Providers must show “meaningful use” by 2015 (maximum reimbursement ends 2012) HITECH/ARRA is just the beginning of the EMR life cycle Enable access to unstructured data from within the EMR with MU certified EHR module Declining Reimbursements Payor denials and lack of timely reimbursements squeeze profits With decreasing profit margins, providers will rely on business analytics tools to help them protect their revenue Accelerate coding, billing, A/R collection and increase visibility of financial KPIs with business analytics ICD-10 Transition ICD-9 to ICD-10 Conversion by October 1, 2014 Over 140,000 new codes in ICD-10 Computer Assisted Coding (CAC) solution addresses ICD-10 conversion issues Streamline Health solutions address critical pain points for providers |
|
|
Growing Addressable Market Current Market Focus Potential New Markets Compelling Market Fundamentals |
|
|
Enterprise Solutions Actionable Information and Knowledge Management Collabra™ Coding and Clinical Documentation Improvement OpportunityAnyWare™ Business Analytics Delivering Actionable Information eCAC eCDI ePhysician Query eAbstract 835DenialWare AuditWare ARWare Solutions Across the Patient Experience The clinical and financial spectrum of an admission or visit Referral Registration Admission Discharge Coding Billing & Collections CDI Reconciliation Audit HIM AccessAnyWare™ Enterprise Content Management CharityWare ReferWare PreOpWare CompletionWare ReleaseWare FolderView Patient Access | Clinicians | HIM | Coding | Clinical Documentation Improvement | Patient Financial Services | Revenue Cycle |
|
|
Current Client Base Frost and Sullivan report: U.S. Hospital Health Data Analytics Market (2012) |
|
|
Case Studies |
|
|
Competitive Landscape ECM / Access AnyWare Coding / Collabra Analytics / Opportunity AnyWare Traditionally compete on solution price, service level, agility, customizability & Industry specific Traditionally compete on solution appeal |
|
|
Go-To-Market Strategy |
|
|
Executive Team Name Title Years of Experience: Previously Streamline Industry Total Robert Watson President & Chief Executive Officer 3 23 32 DocuSys, Concuity, Cerner (NASDAQ: CERN) Nicholas Meeks Senior Vice President & Chief Financial Officer 2 6 9 Emdeon (NYSE: EM), Chamberlin Edmonds Richard Nelli Senior Vice President & Chief Technology Officer 1 22 22 Optum (NYSE: UNH), Caremedic Matthew Seefeld Senior Vice President, Solution Strategy 2 14 16 Interpoint Partners, Deloitte, PwC Michael Schiller Senior Vice President, Sales & Marketing 2 22 22 AllScripts (NASDAQ: MDRX), GE Healthcare (NYSE: GE) Herbert Larsen Senior Vice President, Client Services 1 25 26 Edifecs, Cigna (NYSE: CI), Arthur Andersen Carolyn Zelnio Vice President & Chief Accounting Officer 1 1 16 Aderant, Witness Systems (NASDAQ: WITS), KPMG |
|
|
Financial Performance TTM Q1 13 TTM Q1 12 82.0% Recurring revenue % total 75.8% 45.3% Recurring revenue growth 19.9% 51.1% Gross margin 49.9% $53.0 Backlog ($ millions) $31.4 35% Growth 4% Growth TTM Revenue ($ in millions) TTM Adj. EBITDA ($ in millions) Increasing Recurring Revenue Key Financial Improvements Achieved |
|
|
2013 Strategic Goals and Projections Maintenance $21.5 Key Strategic Goals FY 2013 Revenue ($ in millions) Adj. EBITDA ($ in millions) |
|
|
Company Summary A leading provider of SaaS-based enterprise content management, business analytics, computer assisted coding (CAC), and clinical documentation improvement (CDI) solutions for healthcare providers. NASDAQ: STRM Exchange/Ticker August 9, 2013: $7.57 (52 Week High - $7.80, Low - $3.50) Share Price (52 Week Range) 13.0 million (June 14, 2013) Common Shares Outstanding August 9, 2013: $98.4 million Market Cap $4.0 million (April 30, 2013) Cash $13.4 million (April 30, 2013) Bank Debt $24.8 million (April 30, 2013) TTM Revenue $5.5 million (April 30, 2013) TTM Adj. EBITDA 100 Number of Associates |
